医保办发〔2023〕2号
Notice of the Office of the National Healthcare Security Administration on Issuing the Guidelines for Price Formation of COVID-19 Treatment Drugs (Trial)
国家医疗保障局办公室关于印发《新冠治疗药品价格形成指引(试行)》的通知
Instrument
policy issuance
This document issues the trial guidelines for price formation of COVID-19 treatment drugs, establishing pricing principles and procedures to regulate drug costs.